176 related articles for article (PubMed ID: 18804965)
1. In vitro activity of cidofovir against the emerging Cantagalo virus and the smallpox vaccine strain IOC.
Jesus DM; Moussatché N; Damaso CR
Int J Antimicrob Agents; 2009 Jan; 33(1):75-9. PubMed ID: 18804965
[TBL] [Abstract][Full Text] [Related]
2. An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine.
Damaso CR; Esposito JJ; Condit RC; Moussatché N
Virology; 2000 Nov; 277(2):439-49. PubMed ID: 11080491
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances.
Smee DF; Bailey KW; Wong MH; Tarbet EB
Antivir Chem Chemother; 2011 May; 21(5):201-8. PubMed ID: 21566266
[TBL] [Abstract][Full Text] [Related]
4. Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.
Medaglia ML; Moussatché N; Nitsche A; Dabrowski PW; Li Y; Damon IK; Lucas CG; Arruda LB; Damaso CR
J Virol; 2015 Dec; 89(23):11909-25. PubMed ID: 26378174
[TBL] [Abstract][Full Text] [Related]
5. A PCR-based assay for detection of emerging vaccinia-like viruses isolated in Brazil.
Damaso CR; Reis SA; Jesus DM; Lima PS; Moussatché N
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):39-46. PubMed ID: 16949244
[TBL] [Abstract][Full Text] [Related]
6. Potent antiviral activity of brequinar against the emerging Cantagalo virus in cell culture.
Schnellrath LC; Damaso CR
Int J Antimicrob Agents; 2011 Nov; 38(5):435-41. PubMed ID: 21840180
[TBL] [Abstract][Full Text] [Related]
7. Human and animal infections by vaccinia-like viruses in the state of Rio de Janeiro: a novel expanding zoonosis.
Schatzmayr HG; Costa RV; Gonçalves MC; D'Andréa PS; Barth OM
Vaccine; 2011 Dec; 29 Suppl 4():D65-9. PubMed ID: 22185829
[TBL] [Abstract][Full Text] [Related]
8. Synergistic combination effect of cidofovir and idoxuridine on vaccinia virus replication.
Remichkova M; Petrov N; Galabov AS
Antivir Chem Chemother; 2006; 17(2):53-8. PubMed ID: 17042327
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of severe zoonotic vaccinia virus infection, Southeastern Brazil.
Abrahão JS; Campos RK; Trindade Gde S; Guimarães da Fonseca F; Ferreira PC; Kroon EG
Emerg Infect Dis; 2015 Apr; 21(4):695-8. PubMed ID: 25811411
[TBL] [Abstract][Full Text] [Related]
10. Parapoxviruses are strongly inhibited in vitro by cidofovir.
Nettleton PF; Gilray JA; Reid HW; Mercer AA
Antiviral Res; 2000 Dec; 48(3):205-8. PubMed ID: 11164507
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype.
Kornbluth RS; Smee DF; Sidwell RW; Snarsky V; Evans DH; Hostetler KY
Antimicrob Agents Chemother; 2006 Dec; 50(12):4038-43. PubMed ID: 16982794
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow-fiber infection model system.
McSharry JJ; Deziel MR; Zager K; Weng Q; Drusano GL
Antimicrob Agents Chemother; 2009 Jan; 53(1):129-35. PubMed ID: 18852271
[TBL] [Abstract][Full Text] [Related]
13. Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus.
Jesus DM; Costa LT; Gonçalves DL; Achete CA; Attias M; Moussatché N; Damaso CR
J Virol; 2009 Nov; 83(22):11477-90. PubMed ID: 19726515
[TBL] [Abstract][Full Text] [Related]
14. Passatempo virus, a vaccinia virus strain, Brazil.
Leite JA; Drumond BP; Trindade GS; Lobato ZI; da Fonseca FG; dos SJ; Madureira MC; Guedes MI; Ferreira JM; Bonjardim CA; Ferreira PC; Kroon EG
Emerg Infect Dis; 2005 Dec; 11(12):1935-8. PubMed ID: 16485483
[TBL] [Abstract][Full Text] [Related]
15. Antiviral effect of HPMPC (Cidofovir®), entrapped in cationic liposomes: in vitro study on MDBK cell and BHV-1 virus.
Korvasová Z; Drašar L; Mašek J; Turánek Knotigová P; Kulich P; Matiašovic J; Kovařčík K; Bartheldyová E; Koudelka Š; Škrabalová M; Miller AD; Holý A; Ledvina M; Turánek J
J Control Release; 2012 Jun; 160(2):330-8. PubMed ID: 22326403
[TBL] [Abstract][Full Text] [Related]
16. Zoonotic Brazilian Vaccinia virus: from field to therapy.
Kroon EG; Mota BE; Abrahão JS; da Fonseca FG; de Souza Trindade G
Antiviral Res; 2011 Nov; 92(2):150-63. PubMed ID: 21896287
[TBL] [Abstract][Full Text] [Related]
17. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of cidofovir resistant vaccinia viruses.
Becker MN; Obraztsova M; Kern ER; Quenelle DC; Keith KA; Prichard MN; Luo M; Moyer RW
Virol J; 2008 May; 5():58. PubMed ID: 18479513
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of sea lion poxvirus to cidofovir.
Nollens HH; Gulland FM; Jacobson ER; Hernandez JA; Klein PA; Walsh MT; Condit RC
Antiviral Res; 2008 Oct; 80(1):77-80. PubMed ID: 18485494
[TBL] [Abstract][Full Text] [Related]
20. Reemergence of vaccinia virus during Zoonotic outbreak, Pará State, Brazil.
de Assis FL; Vinhote WM; Barbosa JD; de Oliveira CH; de Oliveira CM; Campos KF; Silva NS; Trindade Gde S;
Emerg Infect Dis; 2013 Dec; 19(12):2017-20. PubMed ID: 24274374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
